chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory distress, Respiratory tract congestion
Clinical narrative: Presents to the ED with C/O SOB, Cough, and Congestion for the last 3-4 days, exposed to COVID.Admitted for Acute Respiratory Distress with Hypoxia, Covid Pneumonia, Hypoxia, and SOB and Cough.  Tx W/ IV Decadron,Rocephin and azithromycin , Zinc,Vitamin-C, zinc, vitamin D3 replacement. Supplemental Oxygen. Remdesivir. D/C home /HHC
Age: 33.0
Sex: F
Vaccine: HEP
Symptoms: Abdominal pain upper, Diarrhoea, Muscle spasms, Vaginal haemorrhage, Vomiting
Clinical narrative: Several hours after receiving the vaccination, I began to experience severe stomach pain and suffered from vomiting and diarrhea. The next morning (8/8/23) I woke up with vaginal bleeding and cramping  that is still continuing as of 8/9/23.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, Mental status changes, Pneumonia
Clinical narrative: Presented w/ weakness, AMS X3 days, cough via EMS. Tx for pneumonia/COVID + w/ O2, Dexamethasone, zinc
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presented w/ weakness, AMS X3 days, cough via EMS. Tx for pneumonia/COVID + w/ O2, Dexamethasone, zinc
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Arrhythmia, Asthenia, COVID-19, COVID-19 pneumonia
Clinical narrative: Presented w/ dehydration, weakeness, SOB, diarrhea. Tx for gastroenteritis, COVID+/pneumonia, electrolyte imbalance, arrhythmia, anemia. Remdesevir, Dexamethasone, O2, Vit C, Zinc
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Diarrhoea, Dyspnoea, Electrolyte imbalance, Gastroenteritis
Clinical narrative: Presented w/ dehydration, weakeness, SOB, diarrhea. Tx for gastroenteritis, COVID+/pneumonia, electrolyte imbalance, arrhythmia, anemia. Remdesevir, Dexamethasone, O2, Vit C, Zinc
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presented w/ dehydration, weakeness, SOB, diarrhea. Tx for gastroenteritis, COVID+/pneumonia, electrolyte imbalance, arrhythmia, anemia. Remdesevir, Dexamethasone, O2, Vit C, Zinc
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Chills, Cough, Decreased appetite
Clinical narrative: Post kidney transplant 11/2017, presented w/ SOB, fatigue, myalgia, chills, sore throat, HA, cough, hematuria and decreased appetite. Covid pneumonia, tx for acute resp. failure w/ hypoxia. O2, IV steroids, abx, IV Remdesivir. D/C home w/ HH on O2.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Haematuria, Headache, Myalgia
Clinical narrative: Post kidney transplant 11/2017, presented w/ SOB, fatigue, myalgia, chills, sore throat, HA, cough, hematuria and decreased appetite. Covid pneumonia, tx for acute resp. failure w/ hypoxia. O2, IV steroids, abx, IV Remdesivir. D/C home w/ HH on O2.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Post kidney transplant 11/2017, presented w/ SOB, fatigue, myalgia, chills, sore throat, HA, cough, hematuria and decreased appetite. Covid pneumonia, tx for acute resp. failure w/ hypoxia. O2, IV steroids, abx, IV Remdesivir. D/C home w/ HH on O2.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Presented w/ COVID+ (+ test one day prior at PCP) and SOB, diarrhea X 1. Tx w/ IV steroids, O2, Remdesivir, Vit C, Zinc
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, COVID-19, Hypoxia, Nausea, Pyrexia
Clinical narrative: Presented w/ abdom. pain, n/v & h/o colon ca. 2014 and recurrent SBOs. COVID+, asymptomatic initially but later developed fever/hypoxia. Tx w/ abx, steroid-Decadron, O2
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Presented w/ abdom. pain, n/v & h/o colon ca. 2014 and recurrent SBOs. COVID+, asymptomatic initially but later developed fever/hypoxia. Tx w/ abx, steroid-Decadron, O2
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, Dyspnoea, Fatigue
Clinical narrative: Presented w/ weakness, cough, SOB, fatigue & tested + COVID at home, one day prior. Tx w/ Dexamethosone
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presented w/ weakness, cough, SOB, fatigue & tested + COVID at home, one day prior. Tx w/ Dexamethosone
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXEMIA
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chemotherapy, Cough, Oropharyngeal pain
Clinical narrative: Presented w/ weakness, cough, sore throat, fever & tested + COVID two days prior. On oral chemo. Tx w/ IV, Remdesivir, steroid, Vit C and Zinc.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Presented w/ weakness, cough, sore throat, fever & tested + COVID two days prior. On oral chemo. Tx w/ IV, Remdesivir, steroid, Vit C and Zinc.
Sex: F
Vaccine: HEP, HEPA
Symptoms: Interchange of vaccine products
Clinical narrative: Interchange of Vaccine/not carry Twinrix at low cost, so they administered a dose of Havrix and Engerix-B on 12Jul2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of interchange of vaccine products in a 43-year-old female patient who received HAV (Havrix) (batch number 772YT, expiry date 23-SEP-2025) for prophylaxis.   Co-suspect products included HBV (Engerix B) (batch number 79S54, expiry date 04-APR-2025) for prophylaxis.   Previously administered products included Twinrix (1st dose received on 16th January 2020 with batch number 53AT5).   On 12-JUL-2023, the patient received Havrix and Engerix B. On 12-JUL-2023, an unknown time after receiving Havrix and Engerix B, the patient experienced interchange of vaccine products (Verbatim: Interchange of Vaccine/not carry Twinrix at low cost, so they administered a dose of Havrix and Engerix-B on 12Jul2023). The outcome of the interchange of vaccine products was unknown.   This report is made without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: Receipt date: 03-AUG-2023 The nurse reported a patient received one dose of Twinrix at a different facility and patient then came in to health department, who did not carry Twinrix at low cost, so they administered a dose of Havrix and Engerix-B. At the time of reporting, no further dosing had been administered. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.  The patient received Twinrix and then Engerix-B and Havrix, which led to interchange of vaccine products.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, COVID-19, Cough, Liver function test increased, Myalgia
Clinical narrative: Presented  w/ cough X 1 wk and n/v, sore throat w/ abdominal pain and myalgia. Covid+ and pancytopenic w/ elevated LFTs. Tx w/ O2, IV Dexamethasone, Zinc.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain, Pancytopenia, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Presented  w/ cough X 1 wk and n/v, sore throat w/ abdominal pain and myalgia. Covid+ and pancytopenic w/ elevated LFTs. Tx w/ O2, IV Dexamethasone, Zinc.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Nausea, Oropharyngeal pain
Clinical narrative: Presented w/ n/v/d, sore throat, cough. Dx Covid+ X 1 wk prior in ED but left AMA. Tx w/ Zinc, IV, Remdesivir and steroids.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Presented w/ n/v/d, sore throat, cough. Dx Covid+ X 1 wk prior in ED but left AMA. Tx w/ Zinc, IV, Remdesivir and steroids.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Hypertension, SARS-CoV-2 test positive
Clinical narrative: Presented w/ SOB, tested covid+ 3 days prior. Worsening sx, HTN. Tx w/ zinc, dexamethasone.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Myalgia, Pain, SARS-CoV-2 test positive
Clinical narrative: Presented w/ sickle cell onset X 2 wks ago, body aches, myalgia and SOB. Covd+, likely to cause sickle cell crisis. Tx w/ Remdesivir, O2, Decadron
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Sickle cell anaemia with crisis
Clinical narrative: Presented w/ sickle cell onset X 2 wks ago, body aches, myalgia and SOB. Covd+, likely to cause sickle cell crisis. Tx w/ Remdesivir, O2, Decadron
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: STABLE ANGINA
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Fall, Pyrexia
Clinical narrative: Presents with weakness, fevers, falls. COVID positive, admission for COVID pneumonia and weakness. Tx w/ Remdesivir,supplemental oxygen,methylprednisolone,Vitamin C, D, zinc, Singulair,Azithromycin and rocephin
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presents with weakness, fevers, falls. COVID positive, admission for COVID pneumonia and weakness. Tx w/ Remdesivir,supplemental oxygen,methylprednisolone,Vitamin C, D, zinc, Singulair,Azithromycin and rocephin
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA NEUROPATHY
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chronic obstructive pulmonary disease, Condition aggravated, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Presented w/ SOB. Tx for COPD exacerbation d/t covid+ pneumonia w/ Dexamethasone and Remdesivir, Zinc and O2.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPERCAPNIC RESPIRATORY FAILURE
Age: 27.0
Sex: F
Vaccine: COVID19-2, SMALLMNK
Symptoms: Dizziness, Hyperhidrosis, Nausea
Clinical narrative: Outreach happened at facility. Client received 2 vaccines (COVID Pfizer BV and MPox) at 11:00am. Client wished to have Hep C testing and STD/STI testing completed. RN made sure client was feeling ok before escorting over to other conference room for client to be tested for Hep C and STD/STI. Client came back into group meeting room where immunizations had occurred at 11:20am. Client stated that she was feeling a little dizzy and a little nauseous. Staff stayed with client while RN went to grab Staff, the client's counselor, from downstairs. Upon returning to room, client stated she still felt dizzy and nauseated, and was slightly diaphoretic. RN asked client if she had eaten anything that day. Client admitted to eating only an orange around 10am and had nothing else to eat. RN offered client some cheese crackers to eat. As soon as client started eating crackers, she stated she started feeling better. Client additionally drank a small cup of orange juice and stated she was feeling much better. Client wanted to complete the Hep C testing and STD/STI testing, so workers came from their conference room into group meeting room to complete finger poke and blood collection for test. No interventions were required as RN used nursing judgement to determine client was most likely experiencing low blood sugar.
Age: 15.0
Sex: F
Vaccine: MMRV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Client was given MMRV that was not recommended for age. Client has had MMR not Varicella. Clients current schedule was put into system. The current record was reviewed with Coordinating nurse and a plan to administer agreed on. To administer these vaccines as a catch-up schedule. The vaccine was reviewed with co-nurse and confirmed. The MMRV was administered and system would not allow it to be logged as administered. The coordinating nurse was advised, and we both reviewed the protocol again. We reviewed the recommended vaccine schedule again. It recommended that the vaccines be separate doses. The client's mother and client were informed of schedule and vaccines administered were incorrect Client and mother stated understanding and continued to agree with separate administration of the MMR and Varicella vaccines required. Event reported to Coordinating nurse and co-nurse.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Sex: F
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: forgot to get the second dose of Shingrix; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose of Shingrix in 2019). Concurrent medical conditions included reflex sympathetic dystrophy.   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: forgot to get the second dose of Shingrix). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 03-AUG-2023 The patient self-reported this case. The patient's pharmacy was closed, and she never received a reminder card. Therefore, she forgot to get the 2nd dose of Shingrix. The patient called for the information on how to resolve the error of not receiving the 2nd dose on time. The reporter did not consent for follow up. Till the date of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypotension, Hypoxia
Clinical narrative: HYPOTENSION ACUTE RESPIRATORY FAILURE HYPOXIA
Age: 61.0
Sex: U
Vaccine: UNK
Symptoms: Loss of personal independence in daily activities, Pain in extremity, Sleep disorder
Clinical narrative: After vaccine, started feeing severe pain on my upper arm. I couldn't take a shower or put my clothes or used seatbelt. Now 08/09 still same pain can't sleep because pain is very acute. I have reported with my Family Dr. as soon as this happened, I was told go to Urgent care, with only adv take tylenol or go back to your doctor. Dr. adv report this issue and requested an MRI scheduled for 08/28/23. I feel that i have handicap instead to feel better is getting worse by the day. This is the first time I had a shingles vaccine.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Coagulopathy, Facial paresis
Clinical narrative: COAGULOPATHY, UNSPECIFIED TYPE ACUTE HYPOXEMIC RESPIRATORY FAILURE RIGHT FACIAL MUSCLE WEAKNESS
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid 19 Infection
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: Mom reported a red, itchy rash on the patient's neck about 2-3 hours after receiving immunizations.  No other symptoms.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia, Respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE HYPERCAPNIC RESPIRATORY FAILURE HYPOXIA
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: NEUROPATHY
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Respiratory failure, Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/5/2022,  2/9/2023,  1/7/2023,  1/26/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Cardiomyopathy, End stage renal disease, Polyneuropathy, Rhinitis allergic
Clinical narrative: G62.9 POLYNEUROPATHY 3/23/2023 CARDIOMYOPATHY, UNSPECIFIED G62.9 POLYNEUROPATHY 3/23/2023 CARDIOMYOPATHY, UNSPECIFIED G62.9 POLYNEUROPATHY 3/23/2023 ALLERGIC RHINITIS G62.9 POLYNEUROPATHY 3/23/2023 CARDIOMYOPATHY, UNSPECIFIED G62.9 POLYNEUROPATHY 3/23/2023 NONTRAUMATIC ACUTE KIDNEY INJURY G62.9 POLYNEUROPATHY 3/23/2023 CARDIOMYOPATHY, UNSPECIFIED G62.9 POLYNEUROPATHY 3/23/2023 ESRD (END STAGE RENAL DISEASE)
Sex: F
Vaccine: VARZOS
Symptoms: Neuropathy peripheral, Pain in extremity, Paraesthesia
Clinical narrative: neuropathy; tingling in feet and legs; pain in legs; This serious case was reported by a nurse via sales rep and described the occurrence of neuropathy in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. In JAN-2023, an unknown time after receiving Shingrix, the patient experienced neuropathy (Verbatim: neuropathy) (serious criteria GSK medically significant), tingling of extremity (Verbatim: tingling in feet and legs) and leg pain (Verbatim: pain in legs). The outcome of the neuropathy, tingling of extremity and leg pain were unknown.   It was unknown if the reporter considered the neuropathy, tingling of extremity and leg pain to be related to Shingrix.     It was unknown if the company considered the neuropathy, tingling of extremity and leg pain to be related to Shingrix.   Additional Information: GSK Receipt date: 04-AUG-2023 The reporter is a Nurse Practitioner who informed GSK representative that a patient received Shingrix vaccine and "since January" the patients had experiencing neuropathy, tingling in feet and legs, also pain in legs.  The reporter consented to follow up. This case had been link with US2023AMR106712, reported by the same reporter.; Sender's Comments:  US-GSK-US2023AMR106712:Same reporter, different patient, same events
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperglycaemia, Hypoxia, Type 2 diabetes mellitus
Clinical narrative: R09.02 HYPOXIA 4/11/2023 DM 2 W HYPERGLYCEMIA
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Back pain, Fatigue, Injection site pain, Spinal pain
Clinical narrative: Patient experienced soreness in the mid-point of his back/spine beginning the night of the first injection.  He felt this predominantly when sitting (vs walking).  The type of pain was similar to the injection site (of which we expected the injection site, but not the back), along with significant fatigue.  The back pain site dissipated after a couple of days, and the injection site pain took longer to dissipate.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Parosmia
Clinical narrative: Sense of taste of taste buds are off still. I only can taste the food when it hits the back of my throat it?s been like this since days after the vaccine I tried to wait and see if it would go away but it hasn?t.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral artery occlusion, Cerebrovascular accident, Dysarthria, Ischaemic stroke, Nephrogenic anaemia
Clinical narrative: I63.511 ACUTE STROKE DUE TO OCCLUSION OF RIGHT MIDDLE CEREBRAL ARTERY 4/22/2023 DYSARTHRIA, LATE EFFECT OF ISCHEMIC STROKE I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/27/2023 DYSARTHRIA, LATE EFFECT OF ISCHEMIC STROKE I63.511 ACUTE STROKE DUE TO OCCLUSION OF RIGHT MIDDLE CEREBRAL ARTERY 4/22/2023 ANEMIA DUE TO CKD I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/27/2023 ANEMIA DUE TO CKD
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Reversible ischaemic neurological deficit
Clinical narrative: I63.511 ACUTE STROKE DUE TO OCCLUSION OF RIGHT MIDDLE CEREBRAL ARTERY 4/22/2023 DYSARTHRIA, LATE EFFECT OF ISCHEMIC STROKE I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/27/2023 DYSARTHRIA, LATE EFFECT OF ISCHEMIC STROKE I63.511 ACUTE STROKE DUE TO OCCLUSION OF RIGHT MIDDLE CEREBRAL ARTERY 4/22/2023 ANEMIA DUE TO CKD I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/27/2023 ANEMIA DUE TO CKD
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Cardiac failure congestive, Chronic respiratory failure, Condition aggravated, Deep vein thrombosis
Clinical narrative: I21.4 ACUTE NON ST ELEVATION MI 4/13/2023 CHF EXACERBATION, UNSPECIFIED I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/25/2023 CHF EXACERBATION, UNSPECIFIED I82.433 ACUTE DVT OF BILAT POPLITEAL VEINS 4/13/2023 CHF EXACERBATION, UNSPECIFIED J96.10 CHRONIC RESPIRATORY FAILURE 4/25/2023 CHF EXACERBATION, UNSPECIFIED J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/13/2023 CHF EXACERBATION, UNSPECIFIED
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure, Reversible ischaemic neurological deficit
Clinical narrative: I21.4 ACUTE NON ST ELEVATION MI 4/13/2023 CHF EXACERBATION, UNSPECIFIED I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/25/2023 CHF EXACERBATION, UNSPECIFIED I82.433 ACUTE DVT OF BILAT POPLITEAL VEINS 4/13/2023 CHF EXACERBATION, UNSPECIFIED J96.10 CHRONIC RESPIRATORY FAILURE 4/25/2023 CHF EXACERBATION, UNSPECIFIED J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/13/2023 CHF EXACERBATION, UNSPECIFIED
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXEMIA
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal sleep-related event, Acute respiratory failure, Breathing-related sleep disorder, Cardiac failure congestive, Chronic respiratory failure
Clinical narrative: SLEEP RELATED HYPOVENTILATION OR HYPOXEMIA 3/8/2023 CHF EXACERBATION, UNSPECIFIED ACUTE PULMONARY EMBOLISM 4/17/2023 CHF EXACERBATION, UNSPECIFIED ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 12/27/2022 CHF EXACERBATION, UNSPECIFIED ACUTE DVT OF BILAT FEMORAL VEINS 4/17/2023 CHF EXACERBATION, UNSPECIFIED ACUTE RESPIRATORY FAILURE 2/16/2023 CHF EXACERBATION, UNSPECIFIED  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/17/2023 CHF EXACERBATION, UNSPECIFIED HYPOXEMIA 4/17/2023 CHF EXACERBATION, UNSPECIFIED
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Deep vein thrombosis, Hypoventilation, Hypoxia, Ischaemic stroke
Clinical narrative: SLEEP RELATED HYPOVENTILATION OR HYPOXEMIA 3/8/2023 CHF EXACERBATION, UNSPECIFIED ACUTE PULMONARY EMBOLISM 4/17/2023 CHF EXACERBATION, UNSPECIFIED ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 12/27/2022 CHF EXACERBATION, UNSPECIFIED ACUTE DVT OF BILAT FEMORAL VEINS 4/17/2023 CHF EXACERBATION, UNSPECIFIED ACUTE RESPIRATORY FAILURE 2/16/2023 CHF EXACERBATION, UNSPECIFIED  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/17/2023 CHF EXACERBATION, UNSPECIFIED HYPOXEMIA 4/17/2023 CHF EXACERBATION, UNSPECIFIED
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary embolism, Respiratory failure
Clinical narrative: SLEEP RELATED HYPOVENTILATION OR HYPOXEMIA 3/8/2023 CHF EXACERBATION, UNSPECIFIED ACUTE PULMONARY EMBOLISM 4/17/2023 CHF EXACERBATION, UNSPECIFIED ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 12/27/2022 CHF EXACERBATION, UNSPECIFIED ACUTE DVT OF BILAT FEMORAL VEINS 4/17/2023 CHF EXACERBATION, UNSPECIFIED ACUTE RESPIRATORY FAILURE 2/16/2023 CHF EXACERBATION, UNSPECIFIED  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/17/2023 CHF EXACERBATION, UNSPECIFIED HYPOXEMIA 4/17/2023 CHF EXACERBATION, UNSPECIFIED
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection
Age: 17.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Nausea, Pallor, Syncope
Clinical narrative: Pt had a vasovagal response.  He became pale and felt as though he could vomit.  Pt was placed in supine position and given cold wash rag.  He did eat a popsicle.  Symptoms lasted about 4 minutes.  VSS throughout this time.
Age: 1.0
Sex: F
Vaccine: HEP, HEPA, IPV, MMR, TDAP, VARCEL
Symptoms: Fear, Injection site rash, Pain, Rash, Rash erythematous
Clinical narrative: Resident developed scattered, raised, reddish, irregular shapes rashes in the neck/chest area and right upper arm around the injection site approximately 5 minutes after vaccine administration of Tdap, Hep A and Varizella on the right arm. Patient was assessed, vital signs taken T:98.2 P:79, BP sitting:111/84, O2 sat RA: 99% Pain 4/10, Pt Stated, "I'm scared", rash itchy, non-painful, patient breathing without difficulty, conversant, answering and responding to questions asked with the interpreter. Reassessment 10-15 minutes after vaccination: alert, orientedX3, walking, moving around without any limitations. Instructions to mother provided: to continue to monitor rashes, advice nurse # given and to call if there are further questions, call EMS or bring patient to ER  if difficulty breathing. Patient left the clinic with mother and 2 other siblings, alert, oriented, walkinf without any limitations, breathing freely, with out any distress , denied pain, no itchiness
Age: 1.0
Sex: F
Vaccine: HEP, HEPA, IPV, MMR, TDAP, VARCEL
Symptoms: Rash pruritic, Skin swelling
Clinical narrative: Resident developed scattered, raised, reddish, irregular shapes rashes in the neck/chest area and right upper arm around the injection site approximately 5 minutes after vaccine administration of Tdap, Hep A and Varizella on the right arm. Patient was assessed, vital signs taken T:98.2 P:79, BP sitting:111/84, O2 sat RA: 99% Pain 4/10, Pt Stated, "I'm scared", rash itchy, non-painful, patient breathing without difficulty, conversant, answering and responding to questions asked with the interpreter. Reassessment 10-15 minutes after vaccination: alert, orientedX3, walking, moving around without any limitations. Instructions to mother provided: to continue to monitor rashes, advice nurse # given and to call if there are further questions, call EMS or bring patient to ER  if difficulty breathing. Patient left the clinic with mother and 2 other siblings, alert, oriented, walkinf without any limitations, breathing freely, with out any distress , denied pain, no itchiness
Age: 54.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Arthralgia, Chest pain, Injected limb mobility decreased, Pain, Pain in extremity
Clinical narrative: difficulty in raising or extending the injected arm; chest soreness on side of injection; shoulder pain; right side of her upper body became sore; arm pain/ soreness in the injected arm (Right); This non-serious case was reported by a consumer via call center representative and described the occurrence of injected limb mobility decreased in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (On an unknown date, the patient received 1st dose and experienced injection site pain, refer case - US2023AMR106739).   On 31-JUL-2023, the patient received the 2nd dose of Shingrix (right arm). On 31-JUL-2023, less than a day after receiving Shingrix, the patient experienced pain in arm (Verbatim: arm pain/ soreness in the injected arm (Right)) and general body pain (Verbatim: right side of her upper body became sore). On an unknown date, the patient experienced injected limb mobility decreased (Verbatim: difficulty in raising or extending the injected arm), chest pain (Verbatim: chest soreness on side of injection) and shoulder pain (Verbatim: shoulder pain). The outcome of the injected limb mobility decreased was not resolved and the outcome of the chest pain, pain in arm, shoulder pain and general body pain were unknown.   It was unknown if the reporter considered the injected limb mobility decreased, chest pain, pain in arm, shoulder pain and general body pain to be related to Shingrix.     It was unknown if the company considered the injected limb mobility decreased, chest pain, pain in arm, shoulder pain and general body pain to be related to Shingrix.   Linked case(s) involving the same patient:  US2023AMR106739   Additional Information: GSK Receipt Date: 04-AUG-2023 The patient self-reported this case. The patient reported shoulder and arm pain and chest soreness on side of injection. The patient received the second dose of Shingrix and later that evening she experienced soreness in the injected arm.  The patient stated that the soreness became worse the next day as the whole right side of her upper body became sore.  The patient had difficulty in raising or extending the injected arm. The reporter consented to follow up.; Sender's Comments:  US-GSK-US2023AMR106739:Same reporter, different dose
Age: 54.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pain in extremity
Clinical narrative: difficulty in raising or extending the injected arm; chest soreness on side of injection; shoulder pain; right side of her upper body became sore; arm pain/ soreness in the injected arm (Right); This non-serious case was reported by a consumer via call center representative and described the occurrence of injected limb mobility decreased in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (On an unknown date, the patient received 1st dose and experienced injection site pain, refer case - US2023AMR106739).   On 31-JUL-2023, the patient received the 2nd dose of Shingrix (right arm). On 31-JUL-2023, less than a day after receiving Shingrix, the patient experienced pain in arm (Verbatim: arm pain/ soreness in the injected arm (Right)) and general body pain (Verbatim: right side of her upper body became sore). On an unknown date, the patient experienced injected limb mobility decreased (Verbatim: difficulty in raising or extending the injected arm), chest pain (Verbatim: chest soreness on side of injection) and shoulder pain (Verbatim: shoulder pain). The outcome of the injected limb mobility decreased was not resolved and the outcome of the chest pain, pain in arm, shoulder pain and general body pain were unknown.   It was unknown if the reporter considered the injected limb mobility decreased, chest pain, pain in arm, shoulder pain and general body pain to be related to Shingrix.     It was unknown if the company considered the injected limb mobility decreased, chest pain, pain in arm, shoulder pain and general body pain to be related to Shingrix.   Linked case(s) involving the same patient:  US2023AMR106739   Additional Information: GSK Receipt Date: 04-AUG-2023 The patient self-reported this case. The patient reported shoulder and arm pain and chest soreness on side of injection. The patient received the second dose of Shingrix and later that evening she experienced soreness in the injected arm.  The patient stated that the soreness became worse the next day as the whole right side of her upper body became sore.  The patient had difficulty in raising or extending the injected arm. The reporter consented to follow up.; Sender's Comments:  US-GSK-US2023AMR106739:Same reporter, different dose
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Symptom recurrence
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE 1/14/2023 & 1/25/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Coagulopathy
Clinical narrative: COAGULOPATHY, UNSPECIFIED TYPE
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia supraventricular, Dizziness, Echocardiogram, Electrocardiogram, Electrocardiogram ambulatory abnormal
Clinical narrative: PALPITATIONS, NERVOUSNESS, DIZZINESS
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nervousness, Palpitations, Ventricular extrasystoles
Clinical narrative: PALPITATIONS, NERVOUSNESS, DIZZINESS
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: H1N1 influenza, Rash, Rash pruritic
Clinical narrative: Patient received the vaccine on 8/8/23. Rash/hives developed around 8pm 8/8 on bilateral legs, torso and arm. No viral symptoms. No fever. Rash is itchy. No new foods. No new skin products.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Pallor
Clinical narrative: Patient left exam room after receiving MenQuadfi vaccine and walked into waiting room to check out. There, a receptionist noticed patient was pale and called in two nurses from the office who responded to the event. Nurses obtained vitals and notified patient's provider, Dr, who suggested patient lie down on exam table with feet on stool and continue assessment of vital signs, vital signs stable. Patient remained in office for at least 15min, vital signs remained stable, Mom verbalized she felt comfortable taking patient home, Nurses advised parent to call office with any questions or concerns.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pulmonary embolism
Clinical narrative: ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS ACUTE PULMONARY EMBOLISM
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE RESPIRATORY FAILURE HYPOXEMIA
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOXIA 1/25/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac failure congestive, Chronic obstructive pulmonary disease, Fall, Pulmonary embolism
Clinical narrative: Initially syncope and falls.  She was subsequently diagnosed with congestive heart failure and atrial fibrillation, later had blood clots in her lungs, COPD and oxygen treatment
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: Initially syncope and falls.  She was subsequently diagnosed with congestive heart failure and atrial fibrillation, later had blood clots in her lungs, COPD and oxygen treatment
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 65.0
Sex: M
Vaccine: PNC20
Symptoms: Anosmia
Clinical narrative: partial loss of sense of smell
Sex: U
Vaccine: HEPAB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Twinrix - Late second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in an unspecified number of patients who received HAB (Twinrix) for prophylaxis.   Previously administered products included Twinrix (received 1st dose January 2023).   In APR-2023, the patient received the 2nd dose of Twinrix. In APR-2023, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: Twinrix - Late second dose). The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 4th August 2023 A pharmacist asked for information regarding a couple of patients who received the first dose of Twinrix in January 2023. Then, the HCP mentioned that the 2nd dose was administered in April 2023. The reporter said that patient wanted to receive the third dose on the day of reporting, and asked what was the recommended minimum interval between the second and third dose. The reporter did not provide information about the patient involved in this situation.  The permission to follow up was not requested. The patient received 2nd dose late which led to lengthening of vaccination schedule
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: CHRONIC HYPOTENSION HYPOTENSION 12/22/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid 19 Infection
Age: 10.0
Sex: F
Vaccine: IPV, TDAP, VARCEL
Symptoms: Blood glucose normal, Dizziness, Nervousness, Tremor, Vomiting
Clinical narrative: At 1054am, around 10 minutes after receiving vaccines, the patient was found by clinic staff in the lobby bathroom being brought to the floor by her mother. Mother stated patient vomited and now felt dizzy.  Upon arrival, patient was slowly brought to floor and placed on left side. 1st set of vitals obtained with the following data: BP 118/82; 110HR; 99% O2; blood glucose 117.  Nursing staff cleaned patient off and once assessed, set up to drink some apple juice.. Pt stated she felt better but just felt a little "shaky". Patient alert and oriented. She was conversing with myself and mild shaking noted in hands which quickly resolved as we continued talking.  Patient had just received TDaP, Polio, and Varicella around 10-15 minutes prior to episode.  Patient slowly assisted in standing and walked over to lobby where 3 nursing staff remained with patient and family. Mom, Dad, and sister present. At 1130am, patient left with family after she was cleared by staff to leave. Family counseled on any further side effects to call us or take her to see a provider for further assessment.   The following vitals were obtained: 11:04 BP 116/72; HR 104 99% O2 11:20am BP 102/76; HR 100; 99% O2
Age: 63.0
Sex: F
Vaccine: MENB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Early dose.
Age: 10.0
Sex: F
Vaccine: IPV
Symptoms: Product storage error
Clinical narrative: Filing for formality, Polio temperature excursion, no harm to patient, patient has been informed and will return for revaccination.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral artery occlusion, Cerebrovascular accident, Reversible ischaemic neurological deficit
Clinical narrative: ACUTE STROKE DUE TO OCCLUSION OF LEFT MIDDLE CEREBRAL ARTERY REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Pulmonary embolism, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI ACUTE PULMONARY EMBOLISM 10/15/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 11.0
Sex: M
Vaccine: IPV
Symptoms: Product storage error
Clinical narrative: Filing for formality, Polio temperature excursion, no harm to patient, patient has been informed and will return for revaccination.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Cerebral artery occlusion, Cerebrovascular accident, Symptom recurrence
Clinical narrative: ACUTE STROKE DUE TO OCCLUSION OF LEFT MIDDLE CEREBRAL ARTERY ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/24/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Sex: F
Vaccine: MENB
Symptoms: Intercepted product prescribing error
Clinical narrative: patient with no spleen was prescribed Bexsero by the treating doctor; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of intercepted drug prescribing error in a 74-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Concurrent medical conditions included asplenia.   On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced intercepted drug prescribing error (Verbatim: patient with no spleen was prescribed Bexsero by the treating doctor). The outcome of the intercepted drug prescribing error was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date 4 August 2023 The pharmacist inform that a 74-year-old patient with no spleen was prescribed Bexsero by the treating doctor which led to intercepted drug prescribing error. The reporter consented to follow up.
Age: 13.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Dizziness, Seizure, Syncope
Clinical narrative: Patient complained of dizziness and was offered water to sip while sitting in a chair with arms and a healthcare professional immediately in front of the patient.  Patient then fainted, started to seize, then quickly regained consciousness.  Had patient lie down and elevated her legs. Patient then started shivering and so patient was covered with a blanket.  After laying down for approximately 10 minutes, patient stated she was feeling good enough to sit up.  Patient sat up for another 5 minutes and stated she felt normal.  Patient waited another 5 minutes with her mother and recovered without sequelae.  Patient left under the care of her mother.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Cellulitis, Erythema, Skin warm, Swelling
Clinical narrative: STARTED 8/5/2023, WITH REDNESS, SWEELING AND HOT TO THE TOUCH
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse event Patient received an additional dose of Hep B He was following an alternate vaccine dosing schedule due to perinatal exposure to HBV and an additional dose of Hep B was given when he was given a combination vaccination
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Angioedema, Hypersensitivity
Clinical narrative: ANGIOEDEMA, SUBSEQ ALLERGIC REACTION, INIT
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Urticaria
Clinical narrative: Patient developed a welt 2x3inches with raised injection sites approximately 5 minutes after injection was administered.  Patient was given 5ml of childrens Benadryl and the welt reduced in size. Injection site was still slightly red but not raised.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Blood immunoglobulin G, Blood immunoglobulin M, Epstein-Barr virus test, Erythema multiforme, Fatigue
Clinical narrative: developed rash 6 days after vaccination. Saw urgent care doctor who thought related to recent vaccine. Came to my office for follwup and rash looked most consistent with erythema multiforme.  Labs ordered to see if a possible recent illness could explain the rash or cause the erythema multiforme. Rash is still present.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Full blood count, Herpes simplex test, Laboratory test, Metabolic function test, Mycoplasma test
Clinical narrative: developed rash 6 days after vaccination. Saw urgent care doctor who thought related to recent vaccine. Came to my office for follwup and rash looked most consistent with erythema multiforme.  Labs ordered to see if a possible recent illness could explain the rash or cause the erythema multiforme. Rash is still present.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Rash
Clinical narrative: developed rash 6 days after vaccination. Saw urgent care doctor who thought related to recent vaccine. Came to my office for follwup and rash looked most consistent with erythema multiforme.  Labs ordered to see if a possible recent illness could explain the rash or cause the erythema multiforme. Rash is still present.
Age: 30.0
Sex: F
Vaccine: HEP, TDAP
Symptoms: Hypoaesthesia, Mobility decreased
Clinical narrative: PATIENT IS COMPLAINING THAT ITS HARD TO LIFT UP HER ARM AND AND SHE IS LOOSING SENSITIVITY IN HER RIGHT HAND.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Symptom recurrence
Clinical narrative: ALLERGIC REACTION, INIT 1/13/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 66.0
Sex: M
Vaccine: COVID19-2, VARZOS
Symptoms: Rash, Rash erythematous, Rash macular, Rash pruritic
Clinical narrative: I got extreme red rash over most of my body. Started with arm pits,  back, groin and abdominal areas. The rash eventually covered entire body including portions of my face. The rash consisted of bright red blotches and much tendency to itch.
Age: 24.0
Sex: F
Vaccine: COVID19-2, HEPA, HPV9, TDAP
Symptoms: Dizziness, Feeling hot, Impaired driving ability, Loss of consciousness, Malaise
Clinical narrative: After vaccines were all completed, the pt was seated and stated she wasn't feeling well and was very hot and that she might pass out. Two RNs were present in the room the entire time. Pt was seated in the chair and passed out. One RN was on each side of the pt to ensure she did not fall out of the chair. She was kept in a sitting position while unconscious. Pt experienced seizure like activity for a few seconds and then regained consciousness. Two other RNs were called to the room. Total amount of time the patient was unconscious was less than one minute. Pt was alert and oriented x 3. She was escorted to an exam room where she laid on a cot with feet up and had some juice and crackers. She stated that she has never
Age: 24.0
Sex: F
Vaccine: COVID19-2, HEPA, HPV9, TDAP
Symptoms: Seizure like phenomena
Clinical narrative: After vaccines were all completed, the pt was seated and stated she wasn't feeling well and was very hot and that she might pass out. Two RNs were present in the room the entire time. Pt was seated in the chair and passed out. One RN was on each side of the pt to ensure she did not fall out of the chair. She was kept in a sitting position while unconscious. Pt experienced seizure like activity for a few seconds and then regained consciousness. Two other RNs were called to the room. Total amount of time the patient was unconscious was less than one minute. Pt was alert and oriented x 3. She was escorted to an exam room where she laid on a cot with feet up and had some juice and crackers. She stated that she has never
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Product administered at inappropriate site, Pruritus
Clinical narrative: Redness, itchy. Claims the vaccine was given too low on the arm. Stated the previous vaccine was given too high.
Age: 1.08
Sex: F
Vaccine: MMR, PNC15
Symptoms: Syringe issue
Clinical narrative: As nurse was administering vaccine, vaccine syringe (prefilled) seemed to work fine, however once nurse withdrew needle and safety mechanism was activated the prefilled syringe snapped at the luer-lock hub leaving the child unharmed in the process
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 46.0
Sex: M
Vaccine: HPV9
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: patient got dose 1 prior at age 45 and dose 2 at age 46 (out of pharmacist standing order). no adverse effects occured.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Neuropathy peripheral
Clinical narrative: PERIPHERAL NEUROPATHY HYPOTENSION